ST002

· Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ST002, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002 [NA]